The global Neuroplasticity Market consists of drugs, therapies, cognitive training programs, and other modalities used to enhance synaptic plasticity and facilitate neural regeneration. Cognitive training programs target learning, memory, problem-solving, speech and language skills through activities aimed at enhancing neuronal connections in the brain. The increasing demand for treatment options for neurological disorders and cognitive impairment is driving the development and adoption of cognitive training programs. The Global Neuroplasticity Market Size is estimated to be valued at US$ 7.62 Bn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing demand for cognitive training programs is one of the key trends propelling the growth of the neuroplasticity market. Cognitive training programs help improve various cognitive functions like memory, attention span, problem-solving ability, and language skills through personalized brain exercises and activities. They are increasingly being used in treating mild cognitive impairment, Alzheimer’s disease, Parkinson’s disease, and other neurological and mental health conditions. Advancements in digital technologies are also enabling the development of more effective mobile and online-based cognitive training programs with features like remote monitoring, personalized recommendations, and gamification. This increasing shift towards digital platforms is expected to further drive the demand for cognitive training programs during the forecast period.
Strength: Neuroplasticity market is witnessing rapid growth owing to increasing R&D investments in brain-related disorders and growing demand for relearning techniques.
Weakness: High costs associated with neuroplasticity treatments and lack of full understanding regarding brain functioning pose challenges to market growth.
Opportunity: Rising geriatric population susceptible to brain diseases and untapped growth opportunities in emerging nations present scope for neuroplasticity market expansion.
Threats: Stringent regulations for new treatment approvals and social stigma around certain brain disorders hinder the neuroplasticity market.
The global neuroplasticity market is expected to witness high growth over the forecast period of 2024 to 2030.
Regional analysis: North America currently dominates the neuroplasticity market owing to advanced healthcare infrastructure and rising expenditure on brain health research in the US and Canada. The Asia Pacific region is expected to witness fastest growth due to growing medical tourism industry in China, India, and Southeast Asian nations.
Key players: Key players operating in the neuroplasticity market are Cushman & Wakefield, Tenon Group, Apollo Sindoori, Compass Group PLC, Sodexo, Serco Group PLC, OCS Group, Jones Lang LaSalle, ISS World Services AS, Ecolab Inc., ABM Industries Inc., Aramark Corporation, Vanguard Resources Inc., and Medxcel Facilities Management, among others.
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it